Systemic Al Amyloidosis
📧 Sign up to get email alerts when something new happens for Systemic Al Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis [Phase 2]
Phase 2 trial update on a BCMA/CD3 bispecific antibody for newly diagnosed systemic AL amyloidosis; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Rapid dFLC Response Predict CHR in AL Amyloidosis
Clinical trial investigating whether a rapid dFLC response can predict complete hematologic response in systemic AL amyloidosis. The study i…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis [NA]
A prospective study is evaluating Teclistamab for systemic AL amyloidosis and is currently recruiting at Peking University People's Hospital…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis [Phase 1]
Phase 1 trial of pomalidomide with melphalan and dexamethasone for untreated systemic AL amyloidosis has been terminated.